Visceral Disease in Castration-resistant Prostate Cancer von Pezaro, Carmel J, Omlin, Aurelius, Lorente, David, Nava Rodrigues, Daniel, Ferraldeschi, Roberta, Bianchini, Diletta, Mukherji, Deborah, Riisnaes, Ruth, Altavilla, Amelia, Crespo, Mateus, Tunariu, Nina, de Bono, Johann S, Attard, Gerhardt

Volltext

Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents von Pezaro, Carmel J, Omlin, Aurelius G, Altavilla, Amelia, Lorente, David, Ferraldeschi, Roberta, Bianchini, Diletta, Dearnaley, David, Parker, Christopher, de Bono, Johann S, Attard, Gerhardt

Volltext

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis von Rescigno, Pasquale, Dolling, David, Conteduca, Vincenza, Rediti, Mattia, Bianchini, Diletta, Lolli, Cristian, Ong, Michael, Li, Haoran, Omlin, Aurelius G., Schmid, Sabine, Caffo, Orazio, Zivi, Andrea, Pezaro, Carmel J., Morley, Courtney, Olmos, David, Romero-Laorden, Nuria, Castro, Elena, Saez, Maria I., Mehra, Niven, Smeenk, Stella, Sideris, Spyridon, Gil, Thyerry, Banks, Patricia, Sandhu, Shaneen K., Sternberg, Cora N., De Giorgi, Ugo, De Bono, Johann S.

Volltext

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy von Lawrence, Mitchell G., Obinata, Daisuke, Sandhu, Shahneen, Selth, Luke A., Wong, Stephen Q., Porter, Laura H., Lister, Natalie, Pook, David, Pezaro, Carmel J., Goode, David L., Rebello, Richard J., Clark, Ashlee K., Papargiris, Melissa, Van Gramberg, Jenna, Hanson, Adrienne R., Banks, Patricia, Wang, Hong, Niranjan, Birunthi, Keerthikumar, Shivakumar, Hedwards, Shelley, Huglo, Alisee, Yang, Rendong, Henzler, Christine, Li, Yingming, Lopez-Campos, Fernando, Castro, Elena, Toivanen, Roxanne, Azad, Arun, Bolton, Damien, Goad, Jeremy, Grummet, Jeremy, Harewood, Laurence, Kourambas, John, Lawrentschuk, Nathan, Moon, Daniel, Murphy, Declan G., Sengupta, Shomik, Snow, Ross, Thorne, Heather, Mitchell, Catherine, Pedersen, John, Clouston, David, Norden, Sam, Ryan, Andrew, Dehm, Scott M., Tilley, Wayne D., Pearson, Richard B., Hannan, Ross D., Frydenberg, Mark, Furic, Luc, Taylor, Renea A., Risbridger, Gail P.

Volltext

Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer von Qu, Liang G., Wardan, Hady, Davis, Ian D., Iddawela, Mahesh, Sluka, Pavel, Pezaro, Carmel J.

Volltext

CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition von Lawrence, Mitchell G, Porter, Laura H, Choo, Nicholas, Pook, David, Grummet, Jeremy P, Pezaro, Carmel J, Sandhu, Shahneen, Ramm, Susanne, Luu, Jennii, Bakshi, Andrew, Goode, David L, Sanij, Elaine, Pearson, Richard B, Hannan, Ross D, Simpson, Kaylene J, Taylor, Renea A, Risbridger, Gail P, Furic, Luc

Volltext

Abiraterone acetate: redefining hormone treatment for advanced prostate cancer von Pezaro, Carmel J., Mukherji, Deborah, De Bono, Johann S.

Volltext

New treatment developments applied to elderly patients with advanced prostate cancer von Mukherji, Deborah, Pezaro, Carmel J, Shamseddine, Ali, De Bono, Johann S

Volltext

The Winds of Change: Emerging Therapeutics in Prostate Cancer von Pezaro, Carmel J, Marciscano, Ariel E, Madan, Ravi A

Volltext

Where does chemotherapy fit into prostate cancer treatment? von Ian D Davis, Carmel J Pezaro

Volltext

Late Relapsing Stage I Nonseminoma von PEZARO, Carmel J, MALLESARA, Girish, TONER, Guy C

Volltext

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476) von James, Nicholas D., Clarke, Noel W., Cook, Adrian, Ali, Adnan, Hoyle, Alex P., Attard, Gerhardt, Brawley, Christopher D., Chowdhury, Simon, Cross, William R., Dearnaley, David P., Bono, Johann S., Diaz‐Montana, Carlos, Gilbert, Duncan, Gillessen, Silke, Gilson, Clare, Jones, Rob J., Langley, Ruth E., Malik, Zafar I., Matheson, David J., Millman, Robin, Parker, Chris C., Pugh, Cheryl, Rush, Hannah, Russell, J. Martin, Berthold, Dominik R., Buckner, Michelle L., Mason, Malcolm D., Ritchie, Alastair W. S., Birtle, Alison J., Brock, Susannah J., Das, Prantik, Ford, Dan, Gale, Joanna, Grant, Warren, Gray, Emma K., Hoskin, Peter, Khan, Mohammad M., Manetta, Caroline, McPhail, Neil J., O'Sullivan, Joe M., Parikh, Omi, Perna, Carla, Pezaro, Carmel J., Protheroe, Andrew S., Robinson, Angus J., Rudman, Sarah M., Sheehan, Denise J., Srihari, Narayanan N., Syndikus, Isabel, Tanguay, Jacob S., Thomas, Carys W., Vengalil, Salil, Wagstaff, John, Wylie, James P., Parmar, Mahesh K. B., Sydes, Matthew R.

Volltext

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology von Risbridger, Gail P., Clark, Ashlee K., Porter, Laura H., Toivanen, Roxanne, Bakshi, Andrew, Lister, Natalie L., Pook, David, Pezaro, Carmel J., Sandhu, Shahneen, Keerthikumar, Shivakumar, Quezada Urban, Rosalia, Papargiris, Melissa, Kraska, Jenna, Madsen, Heather B., Wang, Hong, Richards, Michelle G., Niranjan, Birunthi, O’Dea, Samantha, Teng, Linda, Wheelahan, William, Li, Zhuoer, Choo, Nicholas, Ouyang, John F., Thorne, Heather, Devereux, Lisa, Hicks, Rodney J., Sengupta, Shomik, Harewood, Laurence, Iddawala, Mahesh, Azad, Arun A., Goad, Jeremy, Grummet, Jeremy, Kourambas, John, Kwan, Edmond M., Moon, Daniel, Murphy, Declan G., Pedersen, John, Clouston, David, Norden, Sam, Ryan, Andrew, Furic, Luc, Goode, David L., Frydenberg, Mark, Lawrence, Mitchell G., Taylor, Renea A.

Volltext

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476) von James, Nicholas D, Clarke, Noel W, Cook, Adrian, Ali, Adnan, Hoyle, Alex P, Attard, Gert, Brawley, Chris D, Chowdhury, Simon, Cross, William R, Dearnaley, David P, de Bono, Johann S, Montana, Carlos Diaz, Gilbert, Duncan, Gillessen, Silke, Gilson, Clare, Jones, Rob J, Langley, Ruth E, Malik, Zafar I, Matheson, David J, Millman, Robin, Parker, Chris C, Pugh, Cheryl, Rush, Hannah, Russell, J Martin, Berthold, Dominic R, Buckner, Michelle L, Mason, Malcolm D, Ritchie, Alastair Ws, Birtle, Alison J, Brock, Susannah J, Das, Prantik, Ford, Dan, Gale, Joanna, Grant, Warren, Gray, Emma K, Hoskin, Peter, Khan, Mohammad M, Manetta, Caroline, McPhail, Neil J, O'Sullivan, Joe M, Parikh, Omi, Perna, Carla, Pezaro, Carmel J, Protheroe, Andrew S, Robinson, Angus J, Rudman, Sarah M, Sheehan, Denise J, Srihari, Narayanan N, Syndikus, Isabel, Tanguay, Jacob, Thomas, Carys W, Vengalil, Salil, Wagstaff, John, Wylie, James P, Parmar, Mahesh Kb, Sydes, Matthew R

Volltext bestellen

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium von Ruiz-Morales, Jose Manuel, Swierkowski, Marcin, Wells, J. Connor, Fraccon, Anna Paola, Pasini, Felice, Donskov, Frede, Bjarnason, Georg A, Lee, Jae-Lyun, Sim, Hao-Wen, Sliwczynsk, Andrzej, Ptak-Chmielewska, Aneta, Teter, Zbigniew, Beuselinck, Benoit, Wood, Lori A, Yuasa, Takeshi, Pezaro, Carmel, Rini, Brian I, Szczylik, Cezary, Choueiri, Toni K, Heng, Daniel Y.C

Volltext

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Rep... von Gillessen, Silke, Bossi, Alberto, Davis, Ian D., de Bono, Johann, Fizazi, Karim, James, Nicholas D., Mottet, Nicolas, Shore, Neal, Small, Eric, Smith, Matthew, Sweeney, Christopher, Tombal, Bertrand, Aparicio, Ana M., Armstrong, Andrew J., Attard, Gerhardt, Beer, Tomasz M., Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Bulbul, Muhammad, Caffo, Orazio, Cheng, Heather H., Chi, Kim N., Clarke, Caroline S., Clarke, Noel, Daugaard, Gedske, De Santis, Maria, Duran, Ignacio, Eeles, Ros, Efstathiou, Jason, Evans, Christopher P., Fanti, Stefano, Fossati, Nicola, Frydenberg, Mark, George, Daniel, Gleave, Martin, Gravis, Gwenaelle, Halabi, Susan, Heinrich, Daniel, Herrmann, Ken, Higano, Celestia, Hofman, Michael S., Hussain, Maha, Jereczek-Fossa, Barbara Alicja, Jones, Robert, Kanesvaran, Ravindran, Kellokumpu-Lehtinen, Pirkko-Liisa, Khauli, Raja B., Klotz, Laurence, Leibowitz, Raya, Mahal, Brandon A., Maluf, Fernando, Mateo, Joaquin, Matheson, David, Mehra, Niven, Merseburger, Axel, Morgans, Alicia K., Morris, Michael J., Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G., Murthy, Vedang, Nguyen, Paul L., Oh, William K., Ost, Piet, O'Sullivan, Joe M., Padhani, Anwar R., Pezaro, Carmel, Poon, Darren M.C., Pritchard, Colin C., Rathkopf, Dana, Ryan, Charles J., Saad, Fred, Pablo Sade, Juan, Sartor, Oliver A., Scher, Howard I., Sharifi, Nima, Skoneczna, Iwona, Soule, Howard, Spratt, Daniel E., Srinivas, Sandy, Sternberg, Cora N., Steuber, Thomas, Suzuki, Hiroyoshi, Sydes, Matthew R., Taplin, Mary-Ellen, Tilki, Derya, Türkeri, Levent, Uemura, Hiroji, Uemura, Hirotsugu, Vale, Claire L., van Oort, Inge, Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y., Zapatero, Almudena, Zilli, Thomas, Omlin, Aurelius

Volltext

Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100 von RICHARDS, Juliet, AI CHIIN LIM, MCEWAN, Lain J, DE BONO, Johann S, ATTARD, Gerhardt, HAY, Colin W, TAYLOR, Angela E, WINGATE, Anna, NOWAKOWSKA, Karolina, PEZARO, Carmel, CARREIRA, Suzanne, GOODALL, Jane, ARLT, Wiebke

Volltext

Simple prognostic score for metastatic castration‐resistant prostate cancer with incorporation of neutrophil‐to‐lymphocyte ratio von Templeton, Arnoud J., Pezaro, Carmel, Omlin, Aurelius, McNamara, Mairéad G., Leibowitz‐Amit, Raya, Vera‐Badillo, Francisco E., Attard, Gerhardt, de Bono, Johann S., Tannock, Ian F., Amir, Eitan

Volltext

Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic... von Davis, Ian D, Xie, Wanling, Pezaro, Carmel, Donskov, Frede, Wells, J. Connor, Agarwal, Neeraj, Srinivas, Sandy, Yuasa, Takeshi, Beuselinck, Benoit, Wood, Lori A, Ernst, D. Scott, Kanesvaran, Ravindran, Knox, Jennifer J, Pantuck, Allan, Saleem, Sadia, Alva, Ajjai, Rini, Brian I, Lee, Jae-Lyun, Choueiri, Toni K, Heng, Daniel Y.C

Volltext

Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consorti... von Donskov, Frede, Xie, Wanling, Overby, Anders, Wells, J. Connor, Fraccon, Anna P., Sacco, Cosimo S., Porta, Camillo, Stukalin, Igor, Lee, Jae-Lyun, Koutsoukos, Konstantinos, Yuasa, Takeshi, Davis, Ian D., Pezaro, Carmel, Kanesvaran, Ravindran, Bjarnason, Georg A., Sim, Hao-Wen, Rathi, Nityam, Kollmannsberger, Christian K., Canil, Christina M., Choueiri, Toni K., Heng, Daniel Y.C.

Volltext